Combination of mTOR and EGFR Kinase Inhibitors Blocks mTORC1 and mTORC2 Kinase Activity and Suppresses the Progression of Colorectal Carcinoma

Quan Wang(Chongqing Medical University), Chunhai Hao(Indiana University School of Medicine)
PLoS ONE
August 22, 2013
Cited by 19


Related Papers